HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Federico Hinestrosa Selected Research

Federico Hinestrosa Research Topics

Disease

9Infections
05/2024 - 01/2014
4Fibrosis (Cirrhosis)
01/2020 - 08/2015
2Chronic Hepatitis C
12/2021 - 01/2014
1Headache (Headaches)
05/2024
1Liver Diseases (Liver Disease)
12/2021
1Hepatitis
12/2021
1Drug-Related Side Effects and Adverse Reactions
11/2020
1Hepatitis C
12/2019

Drug/Important Bio-Agent (IBA)

6Ribavirin (Virazole)FDA LinkGeneric
12/2019 - 01/2014
6SofosbuvirIBA
12/2019 - 01/2014
3velpatasvirIBA
10/2017 - 12/2015
3Protease Inhibitors (Protease Inhibitor)IBA
11/2016 - 01/2014
3daclatasvirIBA
02/2016 - 01/2014
2Antiviral Agents (Antivirals)IBA
12/2021 - 10/2017
2RNA (Ribonucleic Acid)IBA
11/2020 - 01/2020
1doravirineIBA
05/2024
1islatravirIBA
05/2024
1sofosbuvir drug combination ledipasvirIBA
12/2021
1glecaprevir and pibrentasvirIBA
12/2019
1L 644711 (B-3(+))IBA
12/2019
1NucleotidesIBA
11/2016
1voxilaprevirIBA
11/2016
18- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA
02/2016
1asunaprevirIBA
02/2016
1InterferonsIBA
02/2016
1N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA
01/2014
1telaprevirIBA
01/2014

Therapy/Procedure

4Therapeutics
12/2019 - 01/2014
1Aftercare (After-Treatment)
12/2019
1Retreatment
10/2017